The fundamental valuations of small biotech are at an all-time low. The cash reserves of Big Pharma are at an all-time high. There will therefore inevitably be a huge flurry of takeover activity, in part facilitated by a hyperinflation "cash is trash" environment. I am not rooting for Kazia to be acquired because it can be a buy-and-hold long term fortune maker, but it is likely to be bought relatively soon. Ignore the pessimists. Stay the course.
KZA Price at posting:
81.0¢ Sentiment: Buy Disclosure: Held
